Elecsys HIV combi PT
PMA: BP160050
Tradename: Elecsys HIV combi PT
Manufacturer: Roche Diagnostics.
Indications:
-
Immunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1 (HIV‑1 groups M and O) and HIV‑2 in human serum and plasma. Elecsys HIV combi PT is intended to be used as an aid in the diagnosis of HIV‑1 and/or HIV‑2 infection, including acute or primary HIV‑1 infection. The assay may also be used as an aid in the diagnosis of HIV‑1/HIV‑2 infection in subjects greater than 2 years of age and in pregnant women.
Approval Date: June 21, 2017
Product Information
- Package Insert - Elecsys HIV combi PT
- Package Insert - PreciControl HIV Gen II
- Package Insert - PreciControl HIV; HIV 2 + GrpO
Supporting Documents
- Summary of Safety and Effectiveness - Elecsys HIV combi PT (BP160150.5)
- March 14, 2018 Approval Order - Elecsys HIV combi PT
- June 21, 2017 Approval Order - Elecys HIV combi PT
- Summary of Safety and Effectiveness - Elecsys HIV combi PT